Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity (Deficit)

v3.22.4
Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 14 $ 294 $ (13,826) $ (13,518)
Beginning balance, shares at Dec. 31, 2020 14,114,707      
Issue of common stock - conversion of Senior Unsecured Promissory Note $ 16 22,384 22,400
Issue of common stock conversion of Senior Unsecured Promissory Note, shares 15,803,200      
Issuance of common stock - IPO, net of fees $ 5 64,331 64,336
Issuance of common stock - IPO, net of fees, shares 5,000,000      
Stock-based compensation - Lucid Diagnostics Inc. 2018 Equity Plan 9,134 9,134
Stock-based compensation - PAVmed Inc. 2014 Equity Plan 465 465
Net loss (28,078) (28,078)
Ending balance, value at Dec. 31, 2021 $ 35 96,608 (41,904) 54,739
Ending balance, shares at Dec. 31, 2021 34,917,907      
Stock-based compensation - Lucid Diagnostics Inc. 2018 Equity Plan 13,859 13,859
Stock-based compensation - PAVmed Inc. 2014 Equity Plan 1,132 1,132
Net loss (56,171) (56,171)
Exercise - stock options - Lucid Diagnostics Inc. 2018 Equity Plan $ 1 694 695
Exercise - stock options - Lucid Diagnostics Inc. 2018 Equity Plan, shares 965,341      
Vest - restricted stock awards
Vest restricted stock awards, shares 169,320      
CapNostics, LLC transfer (211) (211)
APA-RDx - Installment Payment 653 653
APA RDx Installment Payment, shares 326,701      
Issuance - Committed Equity Facility, net of financing charges $ 1 1,766 1,767
Issuance - Committed Equity Facility, net of deferred financing charges, shares 680,263      
Purchase - Employee Stock Purchase Plan 109 109
Purchase employee stock purchase plan, shares 84,030      
Issuance - Due To: PAVmed Inc. Settlement in Common Stock $ 4 6,471 6,475
Issuance - Due To: PAVmed Inc. Settlement in Common Stock, shares 3,375,230      
Ending balance, value at Dec. 31, 2022 $ 41 $ 121,081 $ (98,075) $ 23,047
Ending balance, shares at Dec. 31, 2022 40,518,792